.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

SULFAMYLON Drug Profile

« Back to Dashboard

Which patents cover Sulfamylon, and what substitute generic drugs are available?

Sulfamylon is a drug marketed by Mylan Institutional and is included in two NDAs.

The generic ingredient in SULFAMYLON is mafenide acetate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.

Summary for Tradename: SULFAMYLON

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list61
Clinical Trials: see list2
Patent Applications: see list2,326
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SULFAMYLON at DailyMed

Pharmacology for Tradename: SULFAMYLON

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
SULFAMYLON
mafenide acetate
FOR SOLUTION;TOPICAL019832-003Jun 5, 1998RXYesYes► Subscribe► Subscribe
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SULFAMYLON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 19823,497,599► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc